Halobetasol is a lipocortin corticosteroid used to treat inflammatory and pruritic corticosteroid responsive dermatoses.
Halobetasol is a highly potent corticosteroid. It is structurally related to clobetasol. Due to its high potency, it is mainly prescribed in the treatment of severe plaque psoriasis and corticosteroid responsive dermatoses.
Halobetasol Propionate Lotion 0.05% is indicated for the topical treatment of plaque psoriasis in patients 12 years of age and older.
Apply a thin layer of Halobetasol Propionate Lotion 0.05% to the affected skin twice daily for up to two weeks. Rub in gently.
Discontinue therapy when control is achieved. If no improvement is seen within two weeks, reassessment of diagnosis may
be necessary.
Treatment beyond two weeks is not recommended and the total dosage should not exceed 50 grams (50 ml) per week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (HPA) axis {see Warnings and Precautions 5.1].Do not use with occlusive dressings unless directed by a physician.
Halobetasol Propionate Lotion 0.05% is for external use only.
Avoid use on the face, scalp, groin, or axillae.
Halobetasol Propionate Lotion 0.05% is not for ophthalmic, oral, or intravaginal use.
Halobetasol Propionate Lotion 0.05% is a white to off-white lotion. It is supplied in an oval tapered white high-density polyethylene bottle with a white polypropylene disc cap. Each bottle contains 60 mL (59 g) of Halobetasol Propionate Lotion 0.05%.
Store at 25°C (77°F); excursions permitted to 15°C and 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Do not freeze.
Full Prescribing Information: DailyMed